Development of novel antiviral peptides against dengue serotypes 1-4
Dengue infections pose a critical threat to public health worldwide. Since there are no clinically approved antiviral drugs to treat dengue infections caused by the four dengue virus (DENV) serotypes, there is an urgent need to develop effective antivirals. Peptides are promising antiviral candidate...
Saved in:
Main Authors: | Lee, Michelle Felicia, Anasir, Mohd Ishtiaq, Poh, Chit Laa * |
---|---|
Format: | Article |
Published: |
Elsevier
2023
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/2157/ https://www.sciencedirect.com/science/article/abs/pii/S0042682223000223?via%3Dihub |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022) -
Serum Stabilities and Antiviral Activities of Chemically Modified Peptides Against Dengue Serotypes 1–4
by: Lee, Michelle Felicia *, et al.
Published: (2024) -
Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Lee, Michelle Felicia, et al.
Published: (2023) -
Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
by: Raahilah, Zahir Essa, et al.
Published: (2022) -
Innate and adaptive immune evasion by dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)